Amerikanische Gesellschaft für Hirudotherapie

Postactivation inhibition of spontaneously active neurosecretory neurons in the medicinal leech.

Research article published in Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology (2007)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: In vitro / laboratoryGenomik & ProteomikGocht et al. · Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology, 2007

Abstract

Spontaneously active neurosecretory neurons in vertebrate and invertebrate nervous systems share similarities in firing frequencies, spike shapes, inhibition by the transmitters they themselves release and postactivation inhibition, an intensity-dependent period of suppressed spontaneous generation of action potentials following phases of high-frequency activity. High-frequency activation of spontaneously active serotonin-containing Retzius cells in isolated ganglia of the leech Hirudo medicinalis induced prolonged membrane hyperpolarisations causing periods of postactivation inhibition of up to 33 s. The duration of the inhibitory periods was directly related to both the number and rate of spikes during activation and was inversely proportional to a cell's spontaneous firing frequency. The periods of postactivation inhibition remained unaffected by both serotonin depletion through repeated injections of 5,7-dihydroxytryptamine and suppressing the afterhyperpolarisation following each action potential with tetraethylammonium (TEA), iberiotoxin or charybdotoxin, suggesting that neither autoinhibition by synaptic release of serotonin nor calcium-activated potassium channels contribute to the underlying mechanism. In contrast, the postactivation inhibitory period was significantly affected both by differential electrical stimulation of the same Retzius cells via microelectrodes filled with molar concentrations of either Na(+)-acetate or K(+)-acetate, and by partial inhibition of Na(+)/K(+)-ATPase with ouabain. Thus, postactivation inhibition in Retzius cells results from prolonged hyperpolarising activity of Na(+)/K(+)-ATPase stimulated by the accumulation of cytosolic Na(+ )during phases of high-frequency spike activity.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAction PotentialsAnimalsElectric StimulationEnzyme InhibitorsGanglia, InvertebrateHirudo medicinalisIn Vitro TechniquesNeural InhibitionNeuronsNeurosecretory SystemsOuabainPotassium

Zusammenfassung

Postactivation inhibition of spontaneously active neurosecretory neurons in the medicinal leech.

Warum dies für die Hirudotherapie relevant ist

This study examined postactivation inhibition in spontaneously active neurosecretory neurons, specifically the serotonin-containing Retzius cells in isolated ganglia of the medicinal leech, Hirudo medicinalis. The researchers investigated the mechanisms causing prolonged membrane hyperpolarization following high-frequency activation, finding it is driven by Na+/K+-ATPase activity rather than calcium-activated potassium channels or serotonin autoinhibition. This research is relevant to ASH as it explores the fundamental neurophysiology of the primary leech species used in hirudotherapy. However, the scope is strictly limited to basic invertebrate neuroscience using in vitro techniques, providing no insight into the leech secretome, anticoagulant properties, or clinical hirudotherapy applications.

Zitation

Postactivation inhibition of spontaneously active neurosecretory neurons in the medicinal leech.

Gocht et al. · Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology, 2007

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Zur ASH-Bibliothek hinzugefügt: May 28, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.